Medical Marijuana, Inc. Applauds Mexican Senate for Approval of Medical Use of Marijuana

Mexico Political News Site Animal Politico Also Highlights Continued Demand for Medical Marijuana in Mexico

SAN DIEGO, CA – June 16, 2016 – Medical Marijuana, Inc. (OTC: MJNA) announced today that it applauds the Mexican Senate for its unanimous approval of legalizing medicinal marijuana in Mexico. The Senate’s vote supports Mexican President Enrique Pena Nieto’s proposal to reform Mexico’s General Health Law and the country’s Federal Penal Code to relax laws against marijuana, including medical use. In addition, national news outlets in Mexico continue to detail the increasing demand for medical marijuana throughout the country.

The marijuana reform bill, which was unanimously approved by the Mexican Senate on June 15, 2016, authorizes the use and importation of all medicine made with marijuana, subject to Mexican health laws. The bill also permits clinical research for medicines containing marijuana.

“We commend Mexico’s new compassionate approach to cannabis and applaud Mexico lawmakers for making the decision to reform cannabis laws to benefit their citizens,” said Dr. Stuart Titus, CEO of Medical Marijuana, Inc. “We are extremely proud to have been the first company to provide Mexico citizens with access to a medical product based on cannabis (THX-free hemp CBD), and with the Mexico Senate’s decision today, we are looking forward to the opportunity of helping even more citizens that suffer from debilitating medical conditions with medicinal marijuana.”

In addition to the landmark marijuana decision made by the Mexican Senate, national news outlets throughout Mexico continue to show the increase in demand for medical marijuana in the country. Animal Politico, an influential Mexico-City based independent news site dedicated to covering Mexican politics, recently covered the need for additional families across Mexico to gain access to Medical Marijuana Inc.’s RSHO-X cannabidiol (CBD) hemp oil. The story was published on the day after legislators met in a special session to discuss Mexico President Peña Nieto’s initiative to decriminalize marijuana.

The Animal Politico article titled “Cannabis: la lucha de los padres que desafiaron a la justicia Mexicana,” (Cannabis: the struggle of parents who challenge the Mexican justice system), highlights the demand for Medical Marijuna Inc.’s Real Scientific Hemp Oil-X™ (RSHO-X™) across Mexico for families with children suffering from debilitating medical conditions, and some of the challenges that remain for the parents seeking access to medical marijuana for their children.

“We’re grateful that Animal Politico and other news outlets in Mexico continue to bring light to the additional families in Mexico who need access to our hemp oil in order to help their suffering children,” Titus said. “We hope that with today’s decision by the Mexican Senate to legalize medical marijuana, families will experience far fewer roadblocks when it comes to gaining access.”

Medical Marijuana, Inc., started exporting to Mexico to help families gain access to THC-free CBD hemp oil RSHO-X™, after the Health Department of Mexico, COFEPRIS, issued the country’s first-ever government permits on February 2, 2016, to two families, including the Maldonado family whose daughter suffered from a severe form of epilepsy.
Other recent coverage in Mexico of HempMeds® and RSHO-X™ has included:


About HempMeds®

HempMeds® offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMeds® is a corporate portfolio company of Medical Marijuana, Inc. (OTC Pink:MJNA) and the Company’s exclusive master distributor and contracted marketing company. In addition to handling sales and distribution, HempMeds® is the communication hub for the Medical Marijuana Inc. portfolio of companies.

About Medical Marijuana Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit

The Company is committed to consistently providing the highest-quality CBD hemp oil products on the market. To see Medical Marijuana, Inc.’s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.


These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.


Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.


Public Relations Contact:

Andrew Hard

Chief Executive Officer

CMW Media

888-829- 0070

[email protected]


Corporate Business Contact:

Nicholas R. Massalas

Director of Business Development

Medical Marijuana, Inc.

OTC Symbol: MJNA

Toll Free: 888-OTC- MJNA (888-682- 6562)


Investor Relations Contact:

EquiNet, LLC

Toll Free: (877) 964.6463

Office/Direct: (858) 264-6500

Email: [email protected]